The Inhibrx Team

Mark P. Lappe
Mark P. Lappe

Founder, Chief Executive Officer

Brendan P. Eckelman, Ph.D.
Brendan P. Eckelman, Ph.D.

Founder, EVP Chief Scientific Officer

Quinn Deveraux, Ph.D.
Quinn Deveraux, Ph.D.

Founder

Klaus W. Wagner, M.D., Ph.D.
Klaus W. Wagner, M.D., Ph.D.

EVP Chief Medical Officer

Kelly Deck, C.P.A.
Kelly Deck, C.P.A.

Chief Financial Officer

Ashraf Amanullah, Ph.D.
Ashraf Amanullah, Ph.D.

EVP, Chief Technical Operations Officer

David Matly, M.B.A.
David Matly, M.B.A.

EVP, Chief Commercial Officer

Jeffrey Jensen
Jeffrey Jensen

EVP Clinical Operations

Leah Pollema, J.D.
Leah Pollema, J.D.

VP, General Counsel

David Kao, PharmD, M.B.A., RPh
David Kao, PharmD, M.B.A., RPh

VP, Regulatory Affairs

Jack Tsai, M.D., M.B.A.
Jack Tsai, M.D., M.B.A.

VP, Business Development

The Inhibrx Board

Mark P. Lappe

Chairman

Douglas G. Forsyth

Director

Jon Faiz Kayyem, Ph.D.

Director

Kimberly Manhard

Director

Kristiina Vuori, M.D., Ph.D.

Director